NBC New YorkHappening Today: SoCal Wildfires, Brexit, Gene Therapy, Contraceptives, Bryan SingerNBC New YorkGene therapy has freed 10 men from nearly all symptoms of hemophilia for a year so far, in a study that fuels hopes that a one-time treatment ca… Continue reading
News-Medical.net |
Gene therapy shows promising effect against blood clots, study states
News-Medical.net A new study conducted in the Children’s Hospital Of Philadelphia (CHOP) reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. Credit: Sebastian Kaulitzki/ Shutterstock.com. A single blood vessel … Gene therapy shows promise against blood-clotting disease …Borneo Bulletin Online Gene Therapy Shows Promise in Factor IX Coagulant Activity for …Monthly Prescribing Reference |
News-Medical.net |
Gene therapy shows promising effect against blood clots, study states
News-Medical.net A new study conducted in the Children’s Hospital Of Philadelphia (CHOP) reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. Credit: Sebastian Kaulitzki/ Shutterstock.com. A single blood vessel … Gene therapy shows promise against blood-clotting disease …Borneo Bulletin Online Gene Therapy Shows Promise in Factor IX Coagulant Activity for …Monthly Prescribing Reference |
CBC.ca |
‘Wow, it’s actually beating’: Novoheart creates tiny heart-like structure with stem cells to test new drugs
CBC.ca Beating rhythmically and suspended in a jar, tiny heart-like structures made from stem cells are the latest innovation for drug testing — technology that has the potential to save pharmaceutical companies money. They’re developed by Canadian-backed … |
FierceBiotech |
Gilead makes bolt-on CAR–T buy after Kite deal
FierceBiotech This is also not a huge surprise given Kite already had a collaboration with Cell Design from June 2016 based on Kite’s strategy to already build precision-controlled CAR products that can be turned ‘on or off’.” It added that investors “should expect … Gilead swoops in with $567M deal to buy CAR–T 2.0 player Cell Design LabsEndpoints News Gilead, Kite to Acquire Cell Design Labs for Up-to-$567M, Growing CAR–T FootprintGenetic Engineering & Biotechnology News Gilead deepens CAR–T push with deal for Cell DesignBioPharma Dive Xconomy –BioPharma-Reporter.com –Business Wire (press release) all 49 news articles » |